KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash & Current Investments (2016 - 2025)

Boston Scientific's Cash & Current Investments history spans 17 years, with the latest figure at $2.0 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 173.3% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, up 173.3%, while the annual FY2025 figure was $2.0 billion, 173.3% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $2.0 billion at Boston Scientific, up from $1.4 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $3.1 billion in Q2 2024 and bottomed at $123.0 million in Q3 2023.
  • The 5-year median for Cash & Current Investments is $913.0 million (2023), against an average of $1.3 billion.
  • The largest annual shift saw Cash & Current Investments tumbled 93.7% in 2021 before it surged 2069.92% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $2.3 billion in 2021, then plummeted by 45.44% to $1.3 billion in 2022, then dropped by 23.76% to $972.0 million in 2023, then fell by 26.03% to $719.0 million in 2024, then soared by 173.3% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Cash & Current Investments are $2.0 billion (Q4 2025), $1.4 billion (Q3 2025), and $830.0 million (Q2 2025).